Flutialfa O Nasal Spray: A High-Demand PCD Pharma Franchise in ENT & Allergy

About Fluticasone Furoate + Oxymetazoline: The Dual-Action Advantage

Tapping into the Growing Market of Allergic and Respiratory Care

Why Flutialfa O is a High-Profit Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Flutialfa O Nasal Spray

Composition : Fluticasone Furoate 27.5 mcg + Oxymetazoline 50 mcg

Dosage Form : Nasal Spray

Packaging Type : Bottle

Packaging : 7gm

Price : ₹1/-

Please Contact For Best Price

Flutialfa O Nasal Spray is an advanced combination therapy designed to provide comprehensive relief from complex nasal symptoms. With the synergistic power of Fluticasone Furoate (27.5 mcg) and Oxymetazoline (50 mcg), this nasal spray addresses both the immediate discomfort and underlying inflammation. The Oxymetazoline component acts as a potent decongestant, providing instant relief by shrinking swollen nasal tissues, allowing for immediate easier breathing. Concurrently, the Fluticasone Furoate, a powerful corticosteroid, works to reduce the inflammatory response that causes chronic symptoms like sneezing, itching, and a runny nose, making it an ideal long-term solution for patients with allergic rhinitis and sinusitis.

The market for respiratory and allergy medication in India is a rapidly expanding segment, driven by increasing pollution levels, a higher incidence of allergic disorders, and greater patient awareness. This creates a continuous and high-value demand for innovative combination products like Flutialfa O Nasal Spray. This makes it an excellent choice for a PCD pharma franchise. We offer a monopoly-based business model in your designated territory, protecting you from internal competition and allowing you to build a dominant position in the B2B supply chain for specialized ENT clinics, hospitals, and pharmacies.

We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, which is crucial for building trust with specialist healthcare professionals. We provide a complete promotional and marketing kit, including product literature and visual aids, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of a top-quality, high-demand nasal therapy product.

Read More

About the Product

Flutialfa O Nasal Spray is an advanced combination therapy designed to provide comprehensive relief from complex nasal symptoms. With the synergistic power of Fluticasone Furoate (27.5 mcg) and Oxymetazoline (50 mcg), this nasal spray addresses both the immediate discomfort and underlying inflammation. The Oxymetazoline component acts as a potent decongestant, providing instant relief by shrinking swollen nasal tissues, allowing for immediate easier breathing. Concurrently, the Fluticasone Furoate, a powerful corticosteroid, works to reduce the inflammatory response that causes chronic symptoms like sneezing, itching, and a runny nose, making it an ideal long-term solution for patients with allergic rhinitis and sinusitis.

The market for respiratory and allergy medication in India is a rapidly expanding segment, driven by increasing pollution levels, a higher incidence of allergic disorders, and greater patient awareness. This creates a continuous and high-value demand for innovative combination products like Flutialfa O Nasal Spray. This makes it an excellent choice for a PCD pharma franchise. We offer a monopoly-based business model in your designated territory, protecting you from internal competition and allowing you to build a dominant position in the B2B supply chain for specialized ENT clinics, hospitals, and pharmacies.

We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, which is crucial for building trust with specialist healthcare professionals. We provide a complete promotional and marketing kit, including product literature and visual aids, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of a top-quality, high-demand nasal therapy product.

May cause temporary burning, stinging, dryness in the nose, sneezing, or runny nose. Prolonged use (more than 3–5 days) may lead to rebound congestion (rhinitis medicamentosa).

Nasal congestion due to colds or allergies Sinusitis Hay fever or allergic rhinitis Nasal blockage associated with upper respiratory infections

For short-term use only (not more than 3–5 days). Overuse can worsen nasal congestion. Avoid in children below the age recommended by your doctor. Do not share the spray with others to avoid contamination.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children. Ensure cap is closed tightly after use.

Get in Touch